US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 33.585
  • -0.105-0.31%
Trading Feb 26 13:14 ET
14.55BMarket Cap17.58P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
43.55%1.77B
43.55%1.77B
4.78%1.76B
-12.20%2.55B
-40.79%1.53B
-49.18%1.23B
-49.18%1.23B
-24.04%1.68B
-14.50%2.91B
-11.10%2.59B
-Cash and cash equivalents
94.76%929.03M
94.76%929.03M
1.45%950.05M
-18.80%1.76B
-57.33%843M
-72.12%477.01M
-72.12%477.01M
-5.56%936.45M
3.09%2.17B
10.28%1.98B
-Short-term investments
11.26%841.97M
11.26%841.97M
8.94%814.27M
7.29%788.6M
12.56%689.48M
5.54%756.74M
5.54%756.74M
-38.99%747.46M
-43.17%735.01M
-45.30%612.52M
Receivables
20.31%26.96M
20.31%26.96M
-34.32%24.9M
-33.06%23.58M
-42.18%22.23M
-38.78%22.41M
-38.78%22.41M
8.81%37.91M
-0.34%35.23M
-41.59%38.44M
-Other receivables
20.31%26.96M
20.31%26.96M
-34.32%24.9M
-33.06%23.58M
-42.18%22.23M
-38.78%22.41M
-38.78%22.41M
8.81%37.91M
-0.34%35.23M
-41.59%38.44M
Other current assets
-76.79%4.19M
-76.79%4.19M
-26.75%4.97M
-77.58%2.29M
9.63%5.01M
-80.07%18.04M
-80.07%18.04M
-92.51%6.78M
-84.77%10.22M
-15.18%4.57M
Total current assets
41.43%1.8B
41.43%1.8B
3.79%1.79B
-12.68%2.58B
-40.72%1.56B
-50.13%1.27B
-50.13%1.27B
-26.19%1.73B
-15.71%2.95B
-11.78%2.63B
Non current assets
Investments and advances
8.52%16.39B
8.52%16.39B
14.88%16.21B
6.45%15.05B
1.05%14.57B
6.13%15.1B
6.13%15.1B
-7.80%14.11B
-0.45%14.14B
0.15%14.41B
Other non current assets
414.17%33.53M
414.17%33.53M
111.70%42.79M
-6.30%27.56M
-83.99%4.49M
-77.99%6.52M
-77.99%6.52M
-33.98%20.21M
-11.98%29.41M
624.29%28.03M
Total non current assets
8.69%16.42B
8.69%16.42B
15.01%16.25B
6.42%15.08B
0.89%14.57B
5.96%15.11B
5.96%15.11B
-7.85%14.13B
-0.48%14.17B
0.32%14.44B
Total assets
11.24%18.22B
11.24%18.22B
13.79%18.04B
3.13%17.66B
-5.52%16.13B
-2.57%16.38B
-2.57%16.38B
-10.28%15.86B
-3.49%17.12B
-1.75%17.07B
Liabilities
Current liabilities
Payables
-9.30%89.18M
-9.30%89.18M
-12.25%101.2M
2.75%121.96M
-2.17%102.96M
-4.27%98.32M
-4.27%98.32M
-5.34%115.34M
-7.39%118.69M
-14.21%105.24M
-accounts payable
-11.84%13.37M
-11.84%13.37M
61.85%22.06M
303.10%23.42M
73.52%11.55M
91.82%15.17M
91.82%15.17M
-15.42%13.63M
-52.29%5.81M
-0.08%6.66M
-Dividends payable
-8.83%75.81M
-8.83%75.81M
-22.18%79.15M
-12.70%98.54M
-7.28%91.41M
-12.29%83.16M
-12.29%83.16M
-3.80%101.71M
-2.68%112.88M
-15.02%98.58M
Current accrued expenses
89.74%98.06M
89.74%98.06M
204.98%38.41M
3.86%56.25M
-4.58%12.6M
-4.58%51.68M
-4.58%51.68M
-4.58%12.6M
0.00%54.16M
0.00%13.2M
Current debt and capital lease obligation
--997.77M
--997.77M
--996.94M
----
----
----
----
----
--999.37M
--998.44M
-Current debt
--997.77M
--997.77M
--996.94M
----
----
----
----
----
--999.37M
--998.44M
Other current liabilities
503.08%68.6M
503.08%68.6M
--31.2M
--97.49M
--9.02M
-8.27%11.38M
-8.27%11.38M
----
----
----
Current liabilities
676.82%1.25B
676.82%1.25B
812.79%1.17B
-76.48%275.7M
-88.85%124.57M
-86.17%161.38M
-86.17%161.38M
-88.69%127.93M
542.92%1.17B
722.01%1.12B
Non current liabilities
Long term debt and capital lease obligation
7.81%6.61B
7.81%6.61B
7.82%6.61B
24.07%7.6B
0.27%6.14B
0.27%6.14B
0.27%6.14B
0.27%6.13B
-13.78%6.13B
-13.78%6.12B
-Long term debt
7.81%6.61B
7.81%6.61B
7.82%6.61B
24.07%7.6B
0.27%6.14B
0.27%6.14B
0.27%6.14B
0.27%6.13B
-13.78%6.13B
-13.78%6.12B
Other non current liabilities
1,242.22%12.08M
1,242.22%12.08M
-50.62%5.58M
218.13%27.04M
-73.82%3.22M
-64.00%900K
-64.00%900K
--11.3M
4.94%8.5M
--12.3M
Total non current liabilities
7.99%6.63B
7.99%6.63B
7.71%6.62B
24.34%7.63B
0.12%6.14B
0.24%6.14B
0.24%6.14B
0.29%6.14B
-14.19%6.14B
-13.60%6.14B
Total liabilities
25.13%7.88B
25.13%7.88B
24.13%7.78B
8.17%7.9B
-13.58%6.27B
-13.59%6.3B
-13.59%6.3B
-13.59%6.27B
-0.33%7.31B
0.21%7.25B
Shareholders'equity
Share capital
0.00%108K
0.00%108K
0.00%108K
-0.92%108K
0.00%108K
0.93%108K
0.93%108K
0.93%108K
1.87%109K
1.89%108K
-common stock
0.00%108K
0.00%108K
0.00%108K
-0.92%108K
0.00%108K
0.93%108K
0.93%108K
0.93%108K
1.87%109K
1.89%108K
Retained earnings
13.03%2.85B
13.03%2.85B
29.51%2.76B
5.56%2.38B
9.50%2.43B
28.14%2.52B
28.14%2.52B
-14.78%2.13B
-7.90%2.25B
-0.35%2.22B
Paid-in capital
2.29%4.1B
2.29%4.1B
2.52%4.11B
1.72%4.1B
8.96%4.07B
9.42%4.01B
9.42%4.01B
10.29%4.01B
12.90%4.03B
5.54%3.74B
Less: Treasury stock
1.26%2.66M
1.26%2.66M
1.26%2.66M
1.22%2.66M
-6.15%2.65M
-6.31%2.63M
-6.31%2.63M
-5.88%2.62M
-4.47%2.63M
3.36%2.83M
Gains losses not affecting retained earnings
--0
--0
----
----
----
--0
--0
----
----
----
Total stockholders'equity
6.44%6.95B
6.44%6.95B
11.91%6.87B
3.10%6.48B
9.17%6.5B
15.96%6.53B
15.96%6.53B
-0.21%6.14B
4.22%6.28B
3.05%5.95B
Noncontrolling interests
-4.55%3.4B
-4.55%3.4B
-1.67%3.39B
-7.26%3.28B
-13.04%3.36B
-8.71%3.56B
-8.71%3.56B
-19.19%3.45B
-19.38%3.53B
-11.37%3.87B
Total equity
2.56%10.34B
2.56%10.34B
7.03%10.26B
-0.63%9.75B
0.42%9.86B
5.87%10.08B
5.87%10.08B
-7.98%9.59B
-5.71%9.81B
-3.15%9.82B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 43.55%1.77B43.55%1.77B4.78%1.76B-12.20%2.55B-40.79%1.53B-49.18%1.23B-49.18%1.23B-24.04%1.68B-14.50%2.91B-11.10%2.59B
-Cash and cash equivalents 94.76%929.03M94.76%929.03M1.45%950.05M-18.80%1.76B-57.33%843M-72.12%477.01M-72.12%477.01M-5.56%936.45M3.09%2.17B10.28%1.98B
-Short-term investments 11.26%841.97M11.26%841.97M8.94%814.27M7.29%788.6M12.56%689.48M5.54%756.74M5.54%756.74M-38.99%747.46M-43.17%735.01M-45.30%612.52M
Receivables 20.31%26.96M20.31%26.96M-34.32%24.9M-33.06%23.58M-42.18%22.23M-38.78%22.41M-38.78%22.41M8.81%37.91M-0.34%35.23M-41.59%38.44M
-Other receivables 20.31%26.96M20.31%26.96M-34.32%24.9M-33.06%23.58M-42.18%22.23M-38.78%22.41M-38.78%22.41M8.81%37.91M-0.34%35.23M-41.59%38.44M
Other current assets -76.79%4.19M-76.79%4.19M-26.75%4.97M-77.58%2.29M9.63%5.01M-80.07%18.04M-80.07%18.04M-92.51%6.78M-84.77%10.22M-15.18%4.57M
Total current assets 41.43%1.8B41.43%1.8B3.79%1.79B-12.68%2.58B-40.72%1.56B-50.13%1.27B-50.13%1.27B-26.19%1.73B-15.71%2.95B-11.78%2.63B
Non current assets
Investments and advances 8.52%16.39B8.52%16.39B14.88%16.21B6.45%15.05B1.05%14.57B6.13%15.1B6.13%15.1B-7.80%14.11B-0.45%14.14B0.15%14.41B
Other non current assets 414.17%33.53M414.17%33.53M111.70%42.79M-6.30%27.56M-83.99%4.49M-77.99%6.52M-77.99%6.52M-33.98%20.21M-11.98%29.41M624.29%28.03M
Total non current assets 8.69%16.42B8.69%16.42B15.01%16.25B6.42%15.08B0.89%14.57B5.96%15.11B5.96%15.11B-7.85%14.13B-0.48%14.17B0.32%14.44B
Total assets 11.24%18.22B11.24%18.22B13.79%18.04B3.13%17.66B-5.52%16.13B-2.57%16.38B-2.57%16.38B-10.28%15.86B-3.49%17.12B-1.75%17.07B
Liabilities
Current liabilities
Payables -9.30%89.18M-9.30%89.18M-12.25%101.2M2.75%121.96M-2.17%102.96M-4.27%98.32M-4.27%98.32M-5.34%115.34M-7.39%118.69M-14.21%105.24M
-accounts payable -11.84%13.37M-11.84%13.37M61.85%22.06M303.10%23.42M73.52%11.55M91.82%15.17M91.82%15.17M-15.42%13.63M-52.29%5.81M-0.08%6.66M
-Dividends payable -8.83%75.81M-8.83%75.81M-22.18%79.15M-12.70%98.54M-7.28%91.41M-12.29%83.16M-12.29%83.16M-3.80%101.71M-2.68%112.88M-15.02%98.58M
Current accrued expenses 89.74%98.06M89.74%98.06M204.98%38.41M3.86%56.25M-4.58%12.6M-4.58%51.68M-4.58%51.68M-4.58%12.6M0.00%54.16M0.00%13.2M
Current debt and capital lease obligation --997.77M--997.77M--996.94M----------------------999.37M--998.44M
-Current debt --997.77M--997.77M--996.94M----------------------999.37M--998.44M
Other current liabilities 503.08%68.6M503.08%68.6M--31.2M--97.49M--9.02M-8.27%11.38M-8.27%11.38M------------
Current liabilities 676.82%1.25B676.82%1.25B812.79%1.17B-76.48%275.7M-88.85%124.57M-86.17%161.38M-86.17%161.38M-88.69%127.93M542.92%1.17B722.01%1.12B
Non current liabilities
Long term debt and capital lease obligation 7.81%6.61B7.81%6.61B7.82%6.61B24.07%7.6B0.27%6.14B0.27%6.14B0.27%6.14B0.27%6.13B-13.78%6.13B-13.78%6.12B
-Long term debt 7.81%6.61B7.81%6.61B7.82%6.61B24.07%7.6B0.27%6.14B0.27%6.14B0.27%6.14B0.27%6.13B-13.78%6.13B-13.78%6.12B
Other non current liabilities 1,242.22%12.08M1,242.22%12.08M-50.62%5.58M218.13%27.04M-73.82%3.22M-64.00%900K-64.00%900K--11.3M4.94%8.5M--12.3M
Total non current liabilities 7.99%6.63B7.99%6.63B7.71%6.62B24.34%7.63B0.12%6.14B0.24%6.14B0.24%6.14B0.29%6.14B-14.19%6.14B-13.60%6.14B
Total liabilities 25.13%7.88B25.13%7.88B24.13%7.78B8.17%7.9B-13.58%6.27B-13.59%6.3B-13.59%6.3B-13.59%6.27B-0.33%7.31B0.21%7.25B
Shareholders'equity
Share capital 0.00%108K0.00%108K0.00%108K-0.92%108K0.00%108K0.93%108K0.93%108K0.93%108K1.87%109K1.89%108K
-common stock 0.00%108K0.00%108K0.00%108K-0.92%108K0.00%108K0.93%108K0.93%108K0.93%108K1.87%109K1.89%108K
Retained earnings 13.03%2.85B13.03%2.85B29.51%2.76B5.56%2.38B9.50%2.43B28.14%2.52B28.14%2.52B-14.78%2.13B-7.90%2.25B-0.35%2.22B
Paid-in capital 2.29%4.1B2.29%4.1B2.52%4.11B1.72%4.1B8.96%4.07B9.42%4.01B9.42%4.01B10.29%4.01B12.90%4.03B5.54%3.74B
Less: Treasury stock 1.26%2.66M1.26%2.66M1.26%2.66M1.22%2.66M-6.15%2.65M-6.31%2.63M-6.31%2.63M-5.88%2.62M-4.47%2.63M3.36%2.83M
Gains losses not affecting retained earnings --0--0--------------0--0------------
Total stockholders'equity 6.44%6.95B6.44%6.95B11.91%6.87B3.10%6.48B9.17%6.5B15.96%6.53B15.96%6.53B-0.21%6.14B4.22%6.28B3.05%5.95B
Noncontrolling interests -4.55%3.4B-4.55%3.4B-1.67%3.39B-7.26%3.28B-13.04%3.36B-8.71%3.56B-8.71%3.56B-19.19%3.45B-19.38%3.53B-11.37%3.87B
Total equity 2.56%10.34B2.56%10.34B7.03%10.26B-0.63%9.75B0.42%9.86B5.87%10.08B5.87%10.08B-7.98%9.59B-5.71%9.81B-3.15%9.82B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
CG MED EQUIP.
838810
+29.94%
SUZHOUBEARING
430418
+22.35%
4
COCYBER
835207
+21.31%
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
+20.05%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites
Earnings Season Underway
Earnings season is here. What to know?